Stockscreener 앱 받기
10.64
0.76%
0.08
전일 마감가:
$10.56
열려 있는:
$10.595
하루 거래량:
6.56M
Relative Volume:
0.70
시가총액:
$12.25B
수익:
$14.33B
순이익/손실:
$-3.79B
주가수익비율:
-3.3565
EPS:
-3.17
순현금흐름:
$1.84B
1주 성능:
+1.72%
1개월 성능:
+2.80%
6개월 성능:
+28.35%
1년 성능:
-18.65%
1일 변동 폭
$10.48
$10.71
1주일 범위
$10.15
$10.73
52주 변동 폭
$6.85
$13.24
비아트리스 Stock (VTRS) Company Profile
명칭
Viatris Inc
전화
(724) 514-1465
주소
1000 MYLAN BOULEVARD, CANONSBURG
VTRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.64 | 12.16B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
127.69 | 56.36B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.52 | 45.81B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.76 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.32 | 28.67B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
488.43 | 20.92B | 3.08B | 1.24B | 1.07B | 25.61 |
비아트리스 Stock (VTRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 개시 | Truist | Buy |
| 2025-06-06 | 개시 | Goldman | Neutral |
| 2024-07-19 | 재개 | Jefferies | Buy |
| 2023-10-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-23 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2023-04-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-02-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-10 | 업그레이드 | UBS | Sell → Neutral |
| 2022-11-08 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2022-06-14 | 개시 | UBS | Sell |
| 2022-05-10 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | 개시 | Citigroup | Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | 개시 | Argus | Hold |
| 2020-12-14 | 개시 | Bernstein | Mkt Perform |
모두보기
비아트리스 주식(VTRS)의 최신 뉴스
What Do Recent Portfolio Streamlining Moves Mean for Viatris’s True Value in 2025? - Yahoo Finance
Merz fails with PI request in first ever SPC case against Viatris - JUVE Patent
Fondaparinux Market Set to Significantly Grow from 2025 to 2032 | - openPR.com
Viatris to Participate in Upcoming Investor Conferences - PR Newswire
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know - The Globe and Mail
Is Viatris Inc. (VIA) stock inflation resilientJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Can Viatris Inc. (VIA) stock sustain double digit ROETrade Risk Report & Long-Term Safe Investment Plans - newser.com
What market sentiment indicators show for Viatris Inc. (VIA) stockJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - newser.com
Can Viatris Inc. (VIA) stock test all time highsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
(VTRS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Ex-Dividend Reminder: Viatris, Radian Group and Equitable Holdings - Nasdaq
European study shows falling prices, rising costs and shortagesfindings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe | Corporate - EQS News
Is Viatris Inc. stock supported by strong cash flowsInsider Buying & Comprehensive Market Scan Insights - newser.com
How Viatris Inc. (VIA) stock trades pre earningsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Europäische Studie zeigt sinkende Preise, steigende Kosten und EngpässeErgebnisse einer unabhängigen Studie, die während der World AMR Awareness Week von Viatris und Medicines for Europe vorgestellt wurden - PR Newswire
Is it time to cut losses on Viatris Inc.Weekly Trend Recap & Real-Time Stock Entry Alerts - newser.com
Is Viatris Inc. stock recession proof2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
What technical charts say about Viatris Inc. stockJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Will Viatris Inc. (VIA) stock benefit from commodity supercycle2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Why Viatris Inc. stock could be next big winnerJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Will Viatris Inc. stock recover faster than peersMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Can Viatris Inc. (VIA) stock surprise markets with earningsInflation Watch & Safe Entry Point Identification - newser.com
United States General Anesthesia Drugs Market Insights & Growth - openPR.com
What dividend safety score for Viatris Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Viatris Inc. stock outlook for YEARTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Using AI based signals to follow Viatris Inc.2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Viatris Inc. - Ad-hoc-news.de
Viatris Inc. (0A5V.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Viatris Inc. stock a good choice for value investorsWeekly Risk Summary & Growth Focused Stock Reports - newser.com
What does recent volatility data suggest for Viatris Inc.Oil Prices & Growth Focused Stock Reports - newser.com
Viatris at Jefferies Conference: Strategic Growth Plans - Investing.com India
비아트리스 (VTRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
0.51%
자본화:
|
볼륨(24시간):